DK0848615T3 - Muilti-undertyoe-FIV-vacciner - Google Patents

Muilti-undertyoe-FIV-vacciner

Info

Publication number
DK0848615T3
DK0848615T3 DK96928989T DK96928989T DK0848615T3 DK 0848615 T3 DK0848615 T3 DK 0848615T3 DK 96928989 T DK96928989 T DK 96928989T DK 96928989 T DK96928989 T DK 96928989T DK 0848615 T3 DK0848615 T3 DK 0848615T3
Authority
DK
Denmark
Prior art keywords
fiv
methods
compositions
subject invention
cats
Prior art date
Application number
DK96928989T
Other languages
English (en)
Inventor
Janet K Yamamoto
Original Assignee
Univ Florida
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida, Univ California filed Critical Univ Florida
Application granted granted Critical
Publication of DK0848615T3 publication Critical patent/DK0848615T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5156—Animal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • AIDS & HIV (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
DK96928989T 1995-08-25 1996-08-23 Muilti-undertyoe-FIV-vacciner DK0848615T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51938695A 1995-08-25 1995-08-25
EP96928989A EP0848615B1 (en) 1995-08-25 1996-08-23 Multi-subtype fiv vaccines
PCT/US1996/013580 WO1997007817A1 (en) 1995-08-25 1996-08-23 Multi-subtype fiv vaccines

Publications (1)

Publication Number Publication Date
DK0848615T3 true DK0848615T3 (da) 2005-10-03

Family

ID=24068097

Family Applications (2)

Application Number Title Priority Date Filing Date
DK96928989T DK0848615T3 (da) 1995-08-25 1996-08-23 Muilti-undertyoe-FIV-vacciner
DK00111079T DK1090985T3 (da) 1995-08-25 1996-08-23 IL-1-uafhængige felin-afledte T-celler

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK00111079T DK1090985T3 (da) 1995-08-25 1996-08-23 IL-1-uafhængige felin-afledte T-celler

Country Status (17)

Country Link
US (5) US5846825A (da)
EP (2) EP1090985B1 (da)
JP (4) JP4142741B2 (da)
KR (2) KR100502568B1 (da)
AT (2) ATE335809T1 (da)
AU (3) AU728750B2 (da)
BR (1) BR9610343A (da)
CA (1) CA2230029C (da)
DE (3) DE69636440D1 (da)
DK (2) DK0848615T3 (da)
ES (2) ES2269042T3 (da)
HK (1) HK1038584A1 (da)
IL (3) IL163873A0 (da)
NZ (3) NZ502144A (da)
PL (2) PL188041B1 (da)
PT (2) PT848615E (da)
WO (1) WO1997007817A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9610343A (pt) 1995-08-25 1999-12-21 Univ Florida Vacinas de subtipos múltiplos para fiv
US6254872B1 (en) * 1995-08-25 2001-07-03 University Of Florida Multi-subtype FIV vaccines
US6458528B1 (en) * 1998-05-15 2002-10-01 Idexx Laboratories, Inc. Diagnosis of feline immunodeficiency virus infection using ENV/GAG polypeptide markers
AU2002244103A1 (en) 2001-02-22 2002-09-12 University Of Florida Materials and methods for detecting, preventing, and treating hiv and fiv retroviral infection
DK1385540T3 (da) 2001-05-10 2011-10-24 Wyeth Llc Sammensætning og fremgangsmåde til forhøjelse af celledensitet i cellekulturer, der er inficeret med lentivirus
JP2006528244A (ja) 2003-05-12 2006-12-14 ユニバーシティ オブ フロリダ リサーチ ファウンデーション，インコーポレイティド Ｆｉｖ感染予防接種のための材料と方法
US7658927B2 (en) * 2003-05-12 2010-02-09 University Of Florida Research Foundation, Inc. Materials and methods for immunizing against FIV infection
AU2004273076B2 (en) * 2003-09-11 2008-02-14 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
JP4717009B2 (ja) 2003-12-18 2011-07-06 アイデックス ラボラトリーズ インコーポレイテッド ネコ免疫不全ウイルスの検出のための方法と装置
AU2005215629B2 (en) 2004-02-19 2009-01-29 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
JP4662988B2 (ja) * 2004-06-30 2011-03-30 アイデックス ラボラトリーズ インコーポレイテッド ネコ免疫不全ウイルスを検出するための方法および装置
US7285278B2 (en) 2004-06-30 2007-10-23 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
WO2006011920A1 (en) 2004-06-30 2006-02-02 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus (fiv) comprising the use of peptides derived from the v3 region of the fiv env protein
US7291338B2 (en) 2005-03-09 2007-11-06 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
US8394581B2 (en) 2007-07-25 2013-03-12 The Kitasato Institute Test method on feline vaccinated with feline immunodeficiency virus vaccine, and antigen for use in the test
US8809004B2 (en) 2010-04-02 2014-08-19 Idexx Laboratories, Inc. Detection of feline immunodeficiency virus
US8596026B2 (en) * 2010-08-05 2013-12-03 Kraft Foods Group Brands Llc Vacuum flow wrap packaging system and method of packaging

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341439C (en) * 1987-08-26 2003-09-23 Niels C. Pedersen Feline t-lymphotropic lentivirus
US6107077A (en) 1987-08-26 2000-08-22 Yamamoto; Janet K. Feline lymphoid cell lines capable of producing FIV for FIV diagnostics and vaccines
US5118602A (en) 1987-08-26 1992-06-02 The Regents Of The University Of California Feline T-lymphotropic lentivirus assay
WO1992000098A1 (en) * 1990-06-29 1992-01-09 Daniel Zagury Methods of inducing immune response to aids virus
AU2299892A (en) * 1991-07-05 1993-02-11 Regents Of The University Of California, The Feline lymphoid cell lines capable of producing fiv
GB9219936D0 (en) * 1992-09-21 1992-11-04 Pitman Moore Inc Vaccines
WO1994020622A1 (en) * 1993-03-11 1994-09-15 Akzo Nobel N.V. Polypeptide fragment capable of inducing neutralising antibodies against feline immuno-deficiency virus
IT1276509B1 (it) * 1995-03-31 1997-10-31 Istituto Superiore Della Sanit Vaccino per la profilassiimmunitaria dell'infezione da virus della immunodeficienza felina del gatto domestico.
US6254872B1 (en) 1995-08-25 2001-07-03 University Of Florida Multi-subtype FIV vaccines
BR9610343A (pt) 1995-08-25 1999-12-21 Univ Florida Vacinas de subtipos múltiplos para fiv

Also Published As

Publication number Publication date
KR19990044093A (ko) 1999-06-25
JP5339687B2 (ja) 2013-11-13
IL163873A0 (en) 2005-12-18
HK1038584A1 (en) 2002-03-22
EP0848615B1 (en) 2005-06-08
NZ513388A (en) 2006-02-24
JPH11513031A (ja) 1999-11-09
IL123264A (en) 2006-09-05
AU728750B2 (en) 2001-01-18
US20040067242A1 (en) 2004-04-08
US5846825A (en) 1998-12-08
AU772353B2 (en) 2004-04-22
PL325376A1 (en) 1998-07-20
DE69634820T2 (de) 2006-03-23
DE69636440T4 (de) 2007-09-27
JP2005261426A (ja) 2005-09-29
DE69636440T2 (de) 2006-12-21
KR20040047812A (ko) 2004-06-05
EP0848615A1 (en) 1998-06-24
NZ316347A (en) 2000-02-28
US6447993B1 (en) 2002-09-10
JP4142741B2 (ja) 2008-09-03
DK1090985T3 (da) 2006-12-04
WO1997007817A1 (en) 1997-03-06
AU2004203358B2 (en) 2007-10-25
CA2230029A1 (en) 1997-03-06
AU2004203358A1 (en) 2004-08-19
ATE335809T1 (de) 2006-09-15
JP2007284442A (ja) 2007-11-01
US6605282B2 (en) 2003-08-12
IL123264A0 (en) 1998-09-24
JP2013079286A (ja) 2013-05-02
DE69634820D1 (de) 2005-07-14
BR9610343A (pt) 1999-12-21
ES2269042T3 (es) 2007-04-01
PT1090985E (pt) 2006-12-29
PT848615E (pt) 2005-10-31
US7311921B2 (en) 2007-12-25
PL188041B1 (pl) 2004-11-30
KR100482616B1 (ko) 2005-09-02
EP1090985B1 (en) 2006-08-09
ATE297218T1 (de) 2005-06-15
US20080145381A1 (en) 2008-06-19
KR100502568B1 (ko) 2005-07-20
AU6855596A (en) 1997-03-19
US20020172941A1 (en) 2002-11-21
PL186706B1 (pl) 2004-02-27
EP1090985A1 (en) 2001-04-11
ES2242967T3 (es) 2005-11-16
CA2230029C (en) 2012-03-27
JP4413132B2 (ja) 2010-02-10
DE69636440D1 (de) 2006-09-21
AU1972501A (en) 2001-05-03
NZ502144A (en) 2001-09-28

Similar Documents

Publication Publication Date Title
DK0848615T3 (da) Muilti-undertyoe-FIV-vacciner
ATE217196T1 (de) Impfstoff auf urease-basis gegen helicobacter infektionen
NO871313D0 (no) Fremgangsmaate for fremstilling av virusvaksine.
DK437980A (da) Felin infektioest peritonitis-virum og vacciner fremstillet deraf
MXPA05012270A (es) Materiales y metodos para inmunizar en contra de la infeccion por virus de inmunodeficiencia de felino.
DK56389D0 (da) Forhindring og behandling af retroviralt frembragte sygdomme
DK312687A (da) Varicella-zoster virus (vzv), fremgangsmaade til fremstilling deraf og vaccine indeholdende vzv
FI884521A (fi) Menetelmä rokotteen, joka suojaa kissoja kissojen tarttuvalta peritoniitilta, valmistamiseksi
NZ334154A (en) Cross-protective equine herpes virus (EHV-1) vaccine that protects against EHV-1 and EHV-4 and method of making and using the same
Morton Laboratory and field trials of killed Brucella suis type 4 vaccine in reindeer
MX9206216A (es) Preparacion de antigenos y de vacunas del virus de la enfermedad misteriosa, antigenos y vacunas obtenidos para la prevencion de dicha enfermedad
RU2002105550A (ru) Вирусвакцина против инфекционного ларинготрахеита птиц
Thomson IMMUNOLOGICAL AND PROTECTIVE RESPONSES TO A HERPES SIMPLEX VIRUS SUBUNIT VACCINE IN A LABIAL INFECTION MODEL IN MICE.
MX9709347A (es) Micoplasma synoviae no virulento y vacuna del mismo.